Ebola has found its way to United States soil for the first time in history and it has captured the attention of Americans who are asking reasonable questions regarding the current administration's handling of the crisis.
- Why were confirmed Ebola cases brought IN TO the United States for the first time in history...leading of course, to the first Ebola case contracted IN the United States?
- Why wont Obama ban travel to and from nations dealing with Ebola outbreaks?
- Why has the CDC been so incompetent and innaccurate in setting protocol for dealing with active and potential cases?
- Why is the Obama sending the NATIONAL GUARD to a FOREIGN country to deal with MEDICAL concerns?
Sometimes, when it comes to politics, things make sense when you start following the $MONEY TRAIL$.
Before we start exploring the money trail, let's plant a thought that you carry through the rest of this article. Great publicity has been given to the innovative drugs used in experimental treatment of the Ebola patients here in the United States, but the majority of the reporting fails to disclose one extremely important factor in the recovery of these patients...almost ALL of the patients that recovered with drug therapy ALSO received blood transfusions from previous Ebola survivors who have the antibodies in their blood. Such transfusions are a well documented, highly successful and INEXPENSIVE form of treatment for Ebola. As an inexpensive, viable form of treatment, isn't it fair to ask why the CDC doesn't promote a blood bank database with donor lists, patient matching, blood collection facilities, etc.?
Hold that thought.
Now let's consider possibly the greatest high risk/high reward industry in the world...biotech. The investment potential in these industries is extremely volatile and in many cases richly rewarding...especially when companies endeavor to produce life-saving drugs, medicines, treatments, etc. Given the recent Ebola outbreak, it only makes sense that there would be great interest in developing Ebola vaccines.
Let's look at some of the players in the developing Ebola vaccine field.
- Given the recent news, the most notable company may be Mapp Biopharmaceutical, Inc. which produces the experimental drug ZMAPP. ZMAPP, currently made using tobacco plants which can be induced to grow antibodies in the drug, has been highly publicized due to the successful recovery of victims brought to the United States for treatment. When supplies ran out in August, the Bill and Melinda Gates Foundation gave $150,000 to ZMAPP to determine if mass production is feasible.
- Amgen, Inc. has also announced it is working with the Gates Foundation to research alternative production using hamster cells and existing manufacturing systems.
- Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference (RNAi) therapeutics, is developing the drug, "TKM-Ebola" under a $140 million contract with the U.S. Department of Defense’s Medical Countermeasure Systems BioDefense Therapeutics Joint Product Management Office. Tekmira Pharmaceuticals Corporation recently received a $1.5 million investment from Monsanto.
- Crucell has been developing an Ebola vaccine for years and in 2006 started the first clinical trials with two groups of 16 volunteers. In 2008, the National Institute of Health and the National Institute of Allergy & Infectious Disease granted awards up $70 million.
Oh...and this sure is interesting! The Canadian Patents Database records Patent Application #CA2741523 in which the owners are recorded as:
"THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES, CENTER FOR DISEASE CONTROL AND PREVENTION".
What is the patent for?
"HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF"
There's also lots of money to be made in other industries....just imagine the slush fund of American tax revenues just waiting to be doled out to various
- COMMITTED GOVERNMENT FUNDS
$88 million to develop medical countermeasures
$66 million for security & laboratory surveillance, logistics and relief commodities and disease detection activities
$10 million for community health workers
$20 million to expand laboratory capacity
$22 million for field hospitals
$2 million for personal protective equipment
- PENDING FUNDS ALREADY APPROVED BY CONGRESS
$58 million to accelerate production and development of antiviral drugs and vaccines
$30 million for CDC personnel, equipment and supplies
$10 million grant by U.S. Agency for International Development to the African Union to train and equip more than 100 medical workers for West Africa
$75 million in additional, unspecified Ebola funds
- ADDITIONAL FUNDS REQUESTED
$1.06 billion transfer request by Defense Dept from current war operations budget to support the Ebola mission
Now its starting to make sense. There's a LOT of money to be made in the Ebola vaccine business...especially if it were to 'tragically' and 'unpredictably' spread to larger regions. There's also a lot of testing to do and likely aren't many healthy American volunteers willing to contract Ebola so these companies can run a trial on their experimental vaccines...so hey...bring in the confirmed Ebola cases!
The appointment of Ron Klain as Obama's new 'Ebola Czar' has raised eyebrows given that he has no experience/training in medicine or healthcare, but these concerns are being waived away by an administration insisting he was hired for his expertise in managing large scale projects.
Klain's management/advisory expertise?
- Served under Attorney General Janet Reno in the Clinton administration
- Served as chief of staff for Vice President Al Gore and was a key figure during the 2000 Florida presidential election recount
- Served as Joe Biden's Chief of Staff, playing a key role in advising the Obama administration on the prospects of an Energy Department loan and PR visit to Solyndra. (Auditors cautioned the administration on the solvency of the company and Klain was among those who simply dismissed the risk as typical of innovative companies. When Solyndra eventually collapsed along with our taxpayer money, investigators revealed numerous connections between investors, lobbyists and campaign donors.)
Klain is a good old boy lawyer and faithful Democratic operative appointed to conduct the money train.